Tirzepatide is a first-in-class investigational peptide being studied for its potent effects on metabolic regulation. As a dual-incretin agonist, it mimics the action of two different natural hormones (GIP and GLP-1) that are involved in blood sugar control and appetite.

By activating both of these receptor pathways, Tirzepatide stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. Research also indicates it can delay gastric emptying, reduce food intake, and improve insulin sensitivity, leading to significant effects on both glycemic control and body weight.

This product is provided as a 50mg vial for research and laboratory purposes only. It is not intended for human consumption or therapeutic use.

• CAS Number: 2023788-19-2